Nautilus Biotechnology NAUT
NASDAQ NAUT
$1.38 +0.26 (+23.87%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nautilus Biotechnology (NAUT) EBT Margin (2026)

Updated

Nautilus Biotechnology's EBT Margin was -8296.32% in Q2 2026.

Analysis

Nautilus Biotechnology (NAUT) EBT Margin (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 16.04%
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 12.10%
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 17.21%
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 36.46%
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 18.13%
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 23.74%
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 19.48%
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 11.12%
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 29.86%
10 Nautilus Biotechnology 141.22 Mn 141.22 Mn 175,000.00 -8,296.32%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,296.32%
API Access

Nautilus Biotechnology EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=NAUT&period=max&api_key=YOUR_API_KEY